ABSTRACT
Moraxella catarrhalis is a human respiratory pathogen that causes acute otitis media in children and is associated with exacerbations in patients suffering from chronic obstructive pulmonary disease (COPD). The first step in M. catarrhalis colonization is adherence to the mucosa, epithelial cells, and extracellular matrix (ECM). The objective of this study was to evaluate the role of M. catarrhalis interactions with collagens from various angles. Clinical isolates (n = 43) were tested for collagen binding, followed by a detailed analysis of protein-protein interactions using recombinantly expressed proteins. M. catarrhalis-dependent interactions with collagen produced by human lung fibroblasts and tracheal tissues were studied by utilizing confocal immunohistochemistry and high-resolution scanning electron microscopy. A mouse smoke-induced chronic obstructive pulmonary disease (COPD) model was used to estimate the adherence of M. catarrhalis in vivo. We found that all M. catarrhalis clinical isolates tested adhered to fibrillar collagen types I, II, and III and network-forming collagens IV and VI. The trimeric autotransporter adhesins ubiquitous surface protein A2 (UspA2) and UspA2H were identified as major collagen-binding receptors. M. catarrhalis wild type adhered to human tracheal tissue and collagen-producing lung fibroblasts, whereas UspA2 and UspA2H deletion mutants did not. Moreover, in the COPD mouse model, bacteria devoid of UspA2 and UspA2H had a reduced level of adherence to the respiratory tract compared to the adherence of wild-type bacteria. Our data therefore suggest that the M. catarrhalis UspA2 and UspA2H-dependent interaction with collagens is highly critical for adherence in the host and, furthermore, may play an important role in the establishment of disease.
IMPORTANCE
The respiratory tract pathogen Moraxella catarrhalis adheres to the host by interacting with several components, including the ECM. Collagen accounts for 30% of total body proteins, and therefore, bacterial adherence to abundant host collagens mediates bacterial persistence and colonization. In this study, we characterized previously unknown M. catarrhalis-dependent interactions with host collagens and found that the trimeric autotransporter adhesins ubiquitous surface protein A2 (UspA2) and UspA2H are highly important. Our observations also suggested that collagen-mediated adherence of M. catarrhalis is indispensable for bacterial survival in the host, as exemplified by a mouse COPD model.
INTRODUCTION
Moraxella catarrhalis is a Gram-negative diplococcus that colonizes the human respiratory tract. The pathogen causes acute otitis media in children and is also associated with bronchitis, sinusitis, laryngitis, and exacerbations in patients with chronic obstructive pulmonary disease (COPD) (1–4). It is frequently found in coinfections with Haemophilus influenzae and/or Streptococcus pneumoniae.
The first step of a successful colonization is adhesion to the host mucosal surface, epithelial cells, and finally, extracellular matrix (ECM). Adhesion is mediated by an array of outer membrane proteins (3), including the M. catarrhalis ubiquitous surface proteins (Usp). This protein family comprises well-characterized trimeric autotransporter adhesins (TAAs), which are recognized as multifunctional virulence factors of M. catarrhalis (5–9). Ubiquitous surface proteins occur as lollipoplike structures that consist of a membrane anchor, stalk, neck, and head domain on the outer membrane (10). They are further divided into three subgroups, as follows: (i) ubiquitous surface protein A1 (UspA1) is present in all clinical isolates; (ii) UspA2 is found in 75% of strains; and finally, (iii) approximately 25% of clinical isolates carry UspA2H instead of UspA2. Ubiquitous surface protein A1 binds to CAECAM-1 surface receptors, and hence, plays an important role in bacterial colonization (11). Either UspA2 or both UspA1 and UspA2 interact with components of the complement pathway to protect M. catarrhalis from the bactericidal activity of serum, and they also bind to ECM components to enhance adherence to the host (5–8, 12–15).
Collagens are the most abundant glycoproteins of the human body and account for 30% of the total protein mass involved in the formation of structural scaffolds, cell adhesion, and angiogenesis and the development of organs (16, 17). The basic structural unit of a collagen molecule consists of an α-chain (monomer). The α-chains associate into a trimer in a triple-helix form to build a protomer, and these associate further, forming a supramolecular organization. On the basis of their supramolecular arrangements, collagens have been categorized into the following five different groups: fibril-forming collagens, network-forming collagens, FACITs (fibril-associated collagen with interrupted triple helices), MACITs (membrane-associated collagen with interrupted triple helices), and multiplexins (16). The triple-helix region of the α-chains consists of the recurring triplet Gly-X-Y repeated n times in the central part of each α-chain, with X and Y often being proline and hydroxyproline, respectively. The other domains of α-chains, which have ordinary amino acid sequences, are termed noncollagenous (NC) domains and are present at the N- or C-terminal end of α-chains. The NC domains are cleaved off in some protomers (fibril-forming collagens), while they are retained in the network-forming collagens (17).
An individual collagen does not represent a tissue’s specificity; rather, several types of collagens associate to form complex structures by defined protein-protein interactions (17–19). Type I collagen is one of the most abundant, present in all human tissues, whereas type II collagen forms fibrils and associates with hyaline and elastic cartilages, including tracheal cartilage (20). Type III collagen is present in connective tissues (reticulate fibers), such as the skin, lungs, and the vascular system (21). The epithelium of all organs anchors to the underlying tissues by interacting with the basement membrane (BM), which is composed of laminin and collagen IV networks (22). Collagen type VI is abundantly present in the ECM of the respiratory system and is upregulated in COPD (23).
It has previously been shown that M. catarrhalis adheres to collagen IV by its outer membrane IgD-binding protein (MID/Hag) (24). Here, we studied in detail the interactions of M. catarrhalis with various human collagens and further investigated their in vivo relevance. The abundant collagens, including fibril-forming types I, II, and III and network-forming types IV, V, VI, and VIII, were tested for binding with several clinical isolates. Bacterial surface proteins interacting with collagens were identified, and protein-protein interactions were elucidated at the molecular level. Moreover, the biological significance of M. catarrhalis-dependent collagen interactions was verified by using human fibroblasts and upper respiratory tract tissue and was finally examined in an in vivo COPD mouse model. Our results indicate that M. catarrhalis efficiently targets collagens for optimal adherence to host tissues.
RESULTS
M. catarrhalis binds to different fibril- and network-forming collagens.
M. catarrhalis Bc5 and BBH18 wild-type (WT) strains were chosen to test interactions with various collagens. Increasing concentrations of bacteria were added to microtiter plates that had been precoated with collagens. Unbound bacteria were removed by washing, and attached bacteria were analyzed by using anti-Moraxella polyclonal antibodies (PAbs). Our results revealed significant adherence of M. catarrhalis Bc5 to most collagens tested. However, M. catarrhalis Bc5 bound more to collagens II and VI than to collagens I, III, and IV, whereas collagens V and VIII were not targeted by M. catarrhalis (Fig. 1A). In parallel with the enzyme-linked immunosorbent assay (ELISA), we coated glass slides with collagen and visualized the adherence of M. catarrhalis by Gram staining and microscopy. Similar results were observed using this method (Fig. 1B). The other M. catarrhalis strain, BBH18, also adhered to the collagens at significant levels (Fig. 1C and D). In contrast, M. catarrhalis did not adhere to human serum albumin (HSA), which was included as a negative control (Fig. 1B and D). These results clearly indicated that M. catarrhalis has a selective specificity for fibrillar collagens I, II, and III, in addition to network-forming collagens IV and VI. Since the remaining network-forming collagens, types V and VIII, were not targeted by M. catarrhalis, we excluded those from further downstream analyses.
In the next set of experiments, various clinical isolates of M. catarrhalis (5, 25) were selected to verify interactions with collagens. All M. catarrhalis clinical isolates tested bound collagens I, II, III, IV, and VI, but the binding capacity varied between isolates. The mean levels of binding of M. catarrhalis to collagens I, II, III, and VI were significantly higher than the mean level of binding to collagen IV (Fig. 1E). A comparison of various clinical isolates regarding their collagen-binding capacities is shown in Fig. S1 in the supplemental material. Our data thus indicated that clinical M. catarrhalis isolates recognize several human collagens that may contribute to bacterial adherence.
The trimeric autotransporters UspA2 and UspA2H are major collagen-binding proteins of M. catarrhalis.
Trimeric autotransporter adhesins, as exemplified by Yersinia enterocolitica YadA (39), Aggregatibacter actinomycetemcomitans EmaA (26), and Bartonella hensalae BadA (27), bind human collagens. Similarly, the high-molecular-weight TAA MID of M. catarrhalis interacts with collagen IV (24). These previous studies prompted us to investigate whether M. catarrhalis TAAs also recognize an array of human collagen molecules. We performed an ELISA to screen single and multiple mutants of M. catarrhalis TAAs. Interestingly, selective deletion of UspA2 in M. catarrhalis Bc5 (ΔuspA2) resulted in significantly reduced binding to collagens I, II, IV, and VI (Fig. 2A). In contrast to the UspA2 mutant (M. catarrhalis Bc5 ΔuspA2), the mutant devoid of MID (Δmid) had slightly decreased binding to collagen I but not to the other collagens tested (Fig. 2A). Similar results were obtained with M. catarrhalis BBH18 WT and the ΔuspA2 and ΔuspA2H mutants (Fig. 2B). Finally, mutants with deletion of UspA2 or UspA2H in combination with deletion of UspA1 and MID were analyzed, proving that UspA2 and UspA2H played the largest role in Moraxella-dependent adherence to collagens (Fig. 2).
To verify the specificity of UspA2- and UspA2H-dependent collagen binding, we performed a competitive inhibition assay. Fibrillar collagens I, II, and III significantly inhibited the adherence of M. catarrhalis Bc5 and BBH18 to collagens I, II, IV, and VI in comparison to the inhibition by the network-forming collagens IV and VI (Fig. 3A and B). Moreover, fibrillar collagens also blocked the interaction of network-forming collagens (Fig. 3A and B), confirming that both UspA2 and UspA2H have a single domain interacting with collagen. Taken together, our results revealed that UspA2 and UspA2H are the major collagen-binding proteins in M. catarrhalis and that fibrillar collagens are prime targets for optimal adherence.
M. catarrhalis UspA2 and UspA2H target gap regions of fibrillar collagens.
To define molecular interactions between UspA2 and UspA2H and the different collagens, we performed a series of protein-protein interaction studies using a direct binding assay. 125I-labeled recombinant UspA2, UspA2H, and UspA1 were added to microtiter plates coated with collagen. The unbound fractions were removed by washing, and bound proteins were estimated by scintillation counting. In contrast to the results for UspA1, which was used as a negative control, a dose-dependent binding of UspA2 and UspA2H to collagens I and II was observed (Fig. 4A and B).
Collagens are large molecules that can be easily visualized in transmission electron microscopy (TEM). The triple helices of collagens I and II overlap to provide variable thickness of the fibril. In TEM analysis, a light-gray short span between light strands represents the overlapping region, whereas the dark-gray span represents the gap regions (18). Ubiquitous surface proteins were labeled with gold particles (10 nm), added to grids with collagens I or II, and visualized by negative staining. Interestingly, UspA2 and UspA2H bound directly to fibrillar collagens I and II at overlap regions of the triple helices (Fig. 4C and D). Quantification of gold particles in 50 randomly selected regions revealed significantly higher levels of binding of UspA2 and UspA2H than of UspA1 to collagens I and II (see Fig. S2A in the supplemental material). These data were in agreement with the results of our direct binding assay (Fig. 4A and B).
UspA2 and UspA2H bind to NC domains of network-forming collagens IV and VI.
We also measured the interaction of UspAs with network-forming collagens IV and VI by a direct binding assay. 125I-labeled UspA2 and UspA2H bound to these collagens in a dose-dependent manner (Fig. 5A and B). In parallel with the results for fibrillar collagens, UspA1 did not bind collagens IV and VI. Another observation was that M. catarrhalis UspA2 and UspA2H bound slightly more to collagen VI than to collagen IV, a finding that correlated with our findings with intact bacteria (Fig. 2).
The collagen type IV network starts with the formation of dimers of two protomers at their NC domains. In a second phase, dimers interact through their 7S domain (N-terminal NC plus the N-terminal part of the triple helix) to form tetramers (18). UspA2 and UspA2H interacted with the NC domain (dotted arrows) and the N-terminal part (solid arrows) of tetramers (Fig. 5C). The NC and 7S domains, which are nonhelical structures, were thus targeted by M. catarrhalis.
Collagen VI consists of a filamentlike structure with N-terminal and C-terminal noncollagenous domains designated von Willebrand (WVA) domains. It is arranged into tetramers by a combination of four α-chains. The tetramers further polymerize to constitute a beaded filamentlike structure (23). Interestingly, gold-labeled UspA2 and UspA2H only localized to the noncollagenous WVA domains (Fig. 5D). The helical collagenous region was not targeted by either UspA2 or UspA2H. When gold granules were quantified, a significantly higher number of UspA2 and UspA2H molecules than of UspA1 molecules were found to have bound to collagens IV and VI (see Fig. S2B in the supplemental material). This observation supported our results obtained by direct binding of iodine-labeled proteins (Fig. 5A and B). In conclusion, our results indicated that UspA2 and UspA2H specifically bind to the noncollagenous domains of collagens IV and VI.
M. catarrhalis adheres to collagens in human lung fibroblasts and trachea.
Since M. catarrhalis binds purified collagens in vitro (Fig. 1), we wanted also to verify our findings in a fibroblast model. Fibroblasts are found in the lamina propria and produce ECM proteins, including collagens (28). We isolated and expanded primary fibroblasts from lung biopsy specimens and added M. catarrhalis cells that had been labeled with Fm4-64 (red dye) (23). Collagen fibrils, including other ECM proteins, were costained with UspA2-fluorescein isothiocyanate (FITC; green dye) and subjected to confocal microscopy. More pronounced adhesion to fibroblasts was observed with M. catarrhalis strains Bc5 WT and RH4 WT than with the UspA2 and UspA2H mutants (Fig. 6A and B; see also Fig. S3 in the supplemental material). Importantly, at higher magnifications, we observed that M. catarrhalis cells were colocalized with ECM of fibroblasts. These results were also verified by a quantitative adherence assay based upon CFU counting. M. catarrhalis Bc5 and BBH18 adhered significantly more than the corresponding mutants (Fig. 6C). Our experiments thus suggested that UspA2 and UspA2H are essential proteins for maximal adherence to lung fibroblasts.
To further explore the capacity of M. catarrhalis to adhere to fibroblasts, preparations were subjected to SEM. M. catarrhalis Bc5 WT and BBH18 WT adhered to the surface of fibroblasts more efficiently than the corresponding UspA2 and UspA2H mutants (Fig. 7A). Several bacteria were easily seen to be colocalized around collagen fibers (Fig. 7A, zoomed insets). Interestingly, M. catarrhalis WT strains had approximately 6-fold better adherence to the ECM region than to the surface of the fibroblasts (Fig. 7B).
To estimate the levels of adherence of M. catarrhalis strains to primary tissue, sections of human trachea were studied. M. catarrhalis strains Bc5 and BBH18 and their corresponding UspA2 and UspA2H mutants were added to tracheal specimens, and the overall bacterial adherence was estimated. M. catarrhalis mutants devoid of UspA2 or UspA2H adhered less than the WT bacteria (Fig. 7C). Intriguingly, higher magnification of tissue sections revealed that M. catarrhalis adhered to collagen bundles (Fig. 7C, insets). Bacterial adherence was quantified at the surface, epithelial, and subepithelial regions. At the epithelial surface, 3.0-fold more M. catarrhalis Bc5 WT was found than for the UspA2 mutant, and in the case of BBH18, 2.5-fold more WT bacteria were observed than for the corresponding UspA2H mutant (Fig. 7D). Similarly, M. catarrhalis Bc5 and BBH18 WT bound more to the epithelium than the corresponding UspA2 and UspA2H mutants. Interestingly, M. catarrhalis Bc5 and BBH18 adhered to the subepithelial region (lamina propria) approximately 6- to 8-fold more than to the epithelial surface and epithelium (Fig. 7D), an observation that most likely was due to abundant ECM proteins, including collagen. Taken together, our results suggest that M. catarrhalis targets host collagens and that the interaction is mediated by a TAA, either UspA2 or UspA2H.
UspA2 and UspA2H contribute to bacterial adherence and survival in a COPD mouse model.
To investigate the in vivo relevance of our findings, we challenged mice with smoke-induced COPD with M. catarrhalis Bc5 and BBH18 WT strains and their corresponding UspA2 and UspA2H mutants. After 30 min, tracheas were excised and embedded in paraffin, followed by imaging of tissue sections using high-resolution scanning electron microscopy (SEM) (Fig. 8A). As expected, M. catarrhalis UspA2 and UspA2H mutants adhered significantly less than the WT bacteria. Bacteria were seen around the collagen fibrils, and adherence was quantified by counting in several randomly selected parts of the tissue sections (Fig. 8B). In parallel with the experiments done in vitro (Fig. 6 and 7), we found that most M. catarrhalis cells bound to the subepithelial region, which is rich in collagens and other ECM proteins. After tissue homogenization and plating, CFU were counted and revealed higher levels of adherence of UspA2- and UspA2H-expressing M. catarrhalis bacteria (Fig. 8C). In summary, our results with mice having a COPD phenotype suggested that upon host colonization, M. catarrhalis bacteria most likely rely upon UspA2 and UspA2H for maximal interactions with tissue collagens.
DISCUSSION
M. catarrhalis is mostly associated with infections in children and, occasionally, in adults (1–3). Under various pathogenetic conditions, including COPD and emphysema, tissue fibrosis, where collagen expression increases severalfold, is a frequent observation (29–32). Enhanced levels of collagen would be favorable for increased adherence of M. catarrhalis. This bacterial species also adheres to the upper airways by utilizing host surface receptors, such as CAECAM1 to -3 and integrins (via Fn-mediated adherence), which results in a proinflammatory response and, to some extent, bacterial internalization (3). While UspA1 is involved in interactions with epithelial surface receptors, UspA2 and UspA2H recognize predominantly ECM proteins. Our data suggest that M. catarrhalis adheres to cilia at the epithelial cell surface (Fig. 9A). In addition to COPD and lung fibrosis, other primary infections of viral origin may also compromise the epithelial cell barrier, which may lead to increased exposure of the lamina propria. In such a scenario, M. catarrhalis has the opportunity to attach to ECM proteins, including collagens, laminin, and fibronectin, resulting in increased bacterial persistence (Fig. 9B). In order to visualize our hypothesis, a summarizing cartoon is shown in Fig. 9C. This hypothesis is in part supported by our in vivo observations, where COPD model mice with damaged mucosas and changed barriers due to tobacco smoke revealed significantly increased levels of adherence of the bacteria investigated.
It has previously been shown that M. catarrhalis can adhere to collagen IV and that this interaction is mediated by the trimeric autotransporter MID (24). Our detailed adherence assay with several M. catarrhalis clinical isolates revealed strong binding to fibrillar collagens, while network-forming collagen IV was least recognized. The MID-deficient mutants Bc5 and BBH18 did not show any significant differences in interactions with collagen IV in comparison to the interactions of their wild-type counterparts. As reported by Bullard et al. (24), one M. catarrhalis strain, O35E, bound collagen IV via MID. We also found that a few isolates had higher affinities for collagen IV (Fig. 1E). Binding to collagen IV could therefore be related to a few isolates that may reflect various levels of expression of mainly MID. It is evident, however, that M. catarrhalis MID and UspAs have varying amino acid sequences with defined motifs (24, 33) and that the expression of UspA is also variable among clinical isolates (25). Moreover, these characteristics of UspA may explain the differences in collagen binding of clinical isolates. According to our results, collagen IV, which is present in the basement membrane, is not a prime target for all clinical isolates.
Among the TAAs, YadA of Yersinia has been extensively studied for its interactions with fibrillar collagens and peptides derived from these molecules (34). The head region of YadA binds promiscuously to fibrillar collagen. It easily recognizes the Gly-Pro-Hyp single triplet, and a peptide comprising (Gly-Pro-Hyp)6 had a strong interaction with YadA. In fact, the triple-helix regions of fibrillar collagens contain several repeats of Gly-Pro-Hyp, and thus, YadA has been shown to interact at multiple places in the triple helix. In addition, microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) of Gram-positive bacteria, such as Cna from Staphylococcus aureus, bind to collagen triple-helix regions (35). UspA2 and UspA2H are structurally diverse molecules regarding domain length and sequence (25, 36). This is the first report demonstrating interactions of M. catarrhalis UspA2 and UspA2H with fibrillar and network-forming collagens at the structural level. Based upon our EM data, UspA2 and UspA2H both interacted with collagens I and II at the overlap regions of triple helices, confirming that these interactions indeed took place in the triple-helix region (Fig. 4C and D). In contrast, triple-helix regions of collagens IV and VI are not recognized by UspA2 and UspA2H but, rather, by NC domains of the molecules involved (Fig. 5C and D). It will be intriguing to study the precise domains of collagens or Usp molecules that are involved in the interactions. Moreover, the mechanism of binding between Usp and collagen molecules will be of great interest.
In conclusion, we found that M. catarrhalis clinical isolates have a large capacity to adhere to host collagen molecules. The surface TAAs UspA2 and UspA2H are versatile proteins that recognize collagens and promote bacterial adherence to host tissues, consequently increasing survival in the respiratory tract. Our findings on M. catarrhalis-dependent interactions with collagens may be highly valuable for the design of future therapies, including vaccines aiming to control this common respiratory pathogen.
MATERIALS AND METHODS
Bacterial strains and culture conditions.
M. catarrhalis Bc5 and BBH18 and other Moraxella clinical isolates (8) were cultured on chocolate agar plates or in brain heart infusion (BHI), followed by incubation at 37°C in a humid atmosphere at 5% CO2. The M. catarrhalis mutants with single and multiple mutations of uspA1, uspA2, uspA2H, and mid were obtained as described elsewhere. According to the presence of resistance markers, the M. catarrhalis mutants were grown in 1.5 µg ml−1 chloramphenicol, 7 µg ml−1 zeocin, or 20 µg ml−1 kanamycin. The multiple mutants were grown with combinations of antibiotics. Escherichia coli BL21(DE3) was cultured in Luria-Bertani (LB) broth or on LB agar plates at 37°C. E. coli bacteria containing pET26b expression vectors with uspA2 and uspA2H genes (6) were grown in LB medium supplemented with 50 µg ml−1 kanamycin.
Collagen adherence assays.
Different purified collagens (types I, II, III, IV, V, VI, and VIII) were purchased from Sigma (St. Louis, MO), and solutions were prepared and stored according to the manufacturer’s instructions. Equimolar concentrations (50 nM) of all collagens were dissolved in 100 mM Tris-HCl, pH 9.0, distributed into PolySorp (Nunc, Roskilde, Denmark) microtiter plates, and incubated overnight at 4°C. Wells coated with collagen were blocked for 1 h at room temperature (RT) with 2.5% bovine serum albumin (BSA) dissolved in phosphate-buffered saline (PBS). In parallel, M. catarrhalis strains grown overnight were also blocked with PBS-BSA for 1 h at RT. The first row of the microtiter plate was filled with 1 × 107 CFU/ml, and in subsequent rows, serial 3-step dilutions were performed. Plates were incubated for 1 h at RT, followed by washing (4 times) with PBS containing 0.05% Tween 20 (PBST). In the next step, primary rabbit anti-Moraxella polyclonal antibodies (PAbs) (5) were added to wells in 100 µl PBS-BSA, followed by incubation for 1 h at RT. Subsequently, plates were washed three times in PBST, followed by the addition of horseradish peroxidase (HRP)-conjugated swine anti-rabbit PAbs (Dako, Glostrup, Denmark) and incubation for 1 h at RT. Finally, plates were washed three times in PBST, developed, and read at 405 nm in a microtiter plate reader (Sunrise Tecan, Männedorf, Germany).
Glass slides were coated with 100 nM collagen or human serum albumin (HSA) as a control and dried at RT. Slides were thereafter washed 3 times in PBS and incubated with M. catarrhalis at 107 CFU/ml in PBS in a sterile petri dish. After 1 h of incubation at RT, slides were washed 3 times in PBS and adhered bacteria were fixed by heat in a flame. To visualize bacteria, conventional Gram staining was performed, followed by photography in a light microscope (Olympus IX73; Olympus, Tokyo, Japan).
Protein-protein interaction assays.
UspA2 (amino acids 30 to 539 [UspA230–539]) and UspA2H (amino acids 50 to 720) full-length proteins were expressed and purified as described previously (5, 6). Recombinant UspA2 and UspA2H were labeled with 125I by using the tosylchloramide (chloramine-T) method as described elsewhere (6). PolySorp microtiter plates with separable wells (Nunc-Immuno, Roskilde, Denmark) were coated with collagens (50 nM), and the binding of 125I-labeled UspA2 or UspA2H was estimated as described previously (15).
Fibroblast cultures and adherence of M. catarrhalis.
Fibroblasts from lung tissues (23) were cultured in Dulbecco modified Eagle medium (DMEM) (Gibco; Life Technologies, Grand Island, NY) supplemented with glucose and pyruvate in a humid atmosphere with 5% CO2 at 37°C. For infection experiments, cells were seeded into 24-well plates and grown until cells covered the plastic surface. Subsequently, 107 CFU/ml of bacteria was added to each well and the plates incubated for 1 to 2 h at 37°C. Wells were washed 5 times with PBS in order to remove unbound bacteria. Trypsin (50 µl) was added to each well, and after dilution, cells were plated onto chocolate agar plates. After incubation at 37°C overnight, CFU were counted manually.
Confocal microscopy.
Fibroblasts (primary cells) were cultured on glass cover slips. After the cells reached 70 to 80% confluence, coverslips were washed 3 times in PBS and fixed with 4% paraformaldehyde for 10 min. Bacteria were labeled with FM 4-64 (N-[3-triethylammoniumpropyl]-4-{6-[4-(diethylamino) phenyl] hexatrienyl} pyridinium dibromide); Life Technologies) and washed 3 times in PBS to remove excess dye. UspA230–539 was labeled with fluorescein isothiocyanate (FITC) according to the manufacturer’s instructions (Sigma). The unincorporated FITC from the UspA2-FITC complex was removed on a D-10 column (Sephadex G-25; GE Healthcare Life Sciences, Freiburg, Germany). To determine adherence, coverslips were blocked with 1% BSA in PBS for 1 h and incubated with 107 CFU/ml FM 4-64-labeled bacteria in 1% BSA for 1 h at RT. Unbound bacteria were removed by washing 3 times in PBS. Thereafter, 5 nM UspA2-FITC solution in 1% BSA was added. After 30 min of incubation, the coverslips were washed 5 times with PBS and mounted in fluorescent mounting medium (Dako) containing 0.3 µg/ml DAPI (4′,6-diamidino-2-phenylindole dihydrochloride). Images were taken in a confocal Zeiss Axio Observer microscope combined with a laser module for LSM 700 (Carl Zeiss, Göttingen, Germany) and processed using Zen Software.
COPD mouse model.
C57BL/6 female mice (6 to 8 weeks old) were obtained from Jackson Laboratories (Bar Harbor, ME) and housed under standard pathogen-free conditions in an animal facility at Lund University. Mice were kept in 12-h light-dark cycles and fed with standard rodent chow and water ad libitum. All experiments were performed according to the animal research ethics guidelines (Canadian Council on Animal Care; www.ccac.ca). For the COPD model, animals were exposed to smoke from 12 3R4F reference cigarettes without filters (Tobacco and Health Research Institute, University of Kentucky, Lexington, KY) in an SIU-48 whole-body cigarette smoking machine (Promech Lab, Vintrie, Sweden). Mice were exposed for 50 min twice daily for 24 weeks. Control mice were exposed to normal room air only. Mice (n = 3 per group) were anesthetized to a surgical plane using isoflurane. The tracheas were exposed surgically, and bacteria were injected intratracheally. The wound was closed with 5.0 silk sutures, and the animals were allowed to recover. After 30 min, the animals were sacrificed by CO2 exposure, and tracheas, along with lungs, were excised. For estimation of contaminating normal flora, one group of mice was injected with PBS alone and treated similarly as described above. Tracheal tissues were processed for SEM. In parallel, the right lung lobe was excised and homogenized by using a Multi-Gen 7 homogenizer (Pro Scientific, Monroe, CT) in 1 ml chilled PBS, pH 7.4. Lung homogenates (100 µl) were mixed with 100 µl PBS containing 6.86% sucrose. Thereafter, samples were serially diluted and plated on chocolate agar plates. After incubation overnight at 37°C in 5% CO2, CFU were determined by manual counting. All experiments were performed in triplicates.
TEM and SEM.
The interactions of UspA1, UspA2, and UspA2H with collagens were analyzed by negative staining and TEM. Bacterial proteins were labeled with colloidal gold nanoparticles (10 nm; British Biocell International, Cardiff, United Kingdom) as described elsewhere (37). Collagens I, II, IV, and VI were absorbed into 400-mesh carbon-coated copper grids and stained with 0.75% (wt/vol) uranyl formate as recently described in detail (38). The grids were incubated with gold-labeled UspA(s), and after washing, the samples were visualized in a Philips/FEI CM 100 TWIN transmission electron microscope (FEI, Hillsboro, OR) at 60-kV accelerating voltage. Images were recorded with a side-mounted Olympus Veleta camera with a resolution of 2,048 by 2,048 pixels (2K by 2K) using iTEM software. For bacterial interactions, fibroblasts or tissue sections obtained with permission (LU339-00) from the Ethical Committee on Animal Experiments, the Swedish Board of Agriculture, were incubated with 2 × 109 CFU/ml of bacteria for 1 h at 37°C. Unbound bacteria were washed with PBS, and specimens were fixed with 4% formaldehyde and 2.5% glutaraldehyde in PBS for 2 h at RT. Mouse tracheal specimens were fixed overnight in 2.5% glutaraldehyde in cacodylate buffer and washed with cacodylate buffer. Subsequently, samples were dehydrated by using an ascending ethanol series from 50% (vol/vol) up to absolute ethanol and then dried with carbon dioxide. Finally, tissue samples were mounted on aluminum holders, sputtered with 20-nm palladium-gold, and examined in a Philips/FEI XL-30 field emission scanning electron microscope using an Everhart-Tornley secondary electron detector. Images were processed using Scandium software. The electron microscopic work was performed at the Core Facility for Integrated microscopy (Panum Institute, University of Copenhagen). Images were enhanced with pseudocolors in Adobe Photoshop CS6 to visualize bacteria.
Statistical analysis.
Data were analyzed by using GraphPad Prism 6. The statistical analysis was performed according to the data setup by using one-way or two-way analysis of variance (ANOVA). Evaluation of the EM data was performed by counting bacteria in at least 50 different cellular profiles from three different experiments. Data sets were also evaluated by Student’s t test for paired data.
SUPPLEMENTAL MATERIAL
ACKNOWLEDGMENTS
The authors report no potential conflicts of interest.
Funding Statement
This work was supported by grants from the Anna and Edwin Berger Foundation, Åke Wiberg Foundation, Lars Hierta Memorial Foundation, and O. E. and Edla Johansson Foundation, as well as the Swedish Medical Research Council (grant no. K2015-57X-03163-43-4; http://www.vr.se), the Cancer Foundation at the University Hospital in Malmö, and Skåne County Council’s research and development foundation (K.R.), and the Physiographical Society (Forssman’s Foundation) (B.S.).
Footnotes
Citation Singh B, Alvarado-Kristensson M, Johansson M, Hallgren O, Westergren-Thorsson G, Mörgelin M, Riesbeck K. 2016. The respiratory pathogen Moraxella catarrhalis targets collagen for maximal adherence to host tissues. mBio 7(2):e00066-16. doi:10.1128/mBio.00066-16.
REFERENCES
- 1.Murphy TF. 1996. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev 60:267–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Karalus R, Campagnari A. 2000. Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect 2:547–559. doi: 10.1016/S1286-4579(00)00314-2. [DOI] [PubMed] [Google Scholar]
- 3.Su YC, Singh B, Riesbeck K. 2012. Moraxella catarrhalis: from interactions with the host immune system to vaccine development. Future Microbiol 7:1073–1100. doi: 10.2217/fmb.12.80. [DOI] [PubMed] [Google Scholar]
- 4.Murphy TF, Parameswaran GI. 2009. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 49:124–131. doi: 10.1086/599375. [DOI] [PubMed] [Google Scholar]
- 5.Singh B, Al-Jubair T, Voraganti C, Andersson T, Mukherjee O, Su YC, Zipfel P, Riesbeck K. 2015. Moraxella catarrhalis binds plasminogen to evade host innate immunity. Infect Immun 83:3458–3469. doi: 10.1128/IAI.00310-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Singh B, Blom AM, Unal C, Nilson B, Mörgelin M, Riesbeck K. 2010. Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity. Mol Microbiol 75:1426–1444. doi: 10.1111/j.1365-2958.2010.07066.x. [DOI] [PubMed] [Google Scholar]
- 7.Tan TT, Nordström T, Forsgren A, Riesbeck K. 2005. The respiratory pathogen Moraxella catarrhalis adheres to epithelial cells by interacting with fibronectin through ubiquitous surface proteins A1 and A2. J Infect Dis 192:1029–1038. doi: 10.1086/432759. [DOI] [PubMed] [Google Scholar]
- 8.Tan TT, Forsgren A, Riesbeck K. 2006. The respiratory pathogen Moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2. J Infect Dis 194:493–497. doi: 10.1086/505581. [DOI] [PubMed] [Google Scholar]
- 9.Slevogt H, Zabel S, Opitz B, Hocke A, Eitel J, N’Guessan PD, Lucka L, Riesbeck K, Zimmermann W, Zweigner J, Temmesfeld-Wollbrueck B, Suttorp N, Singer BB. 2008. CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat Immunol 9:1270–1278. doi: 10.1038/ni.1661. [DOI] [PubMed] [Google Scholar]
- 10.Łyskowski A, Leo JC, Goldman A. 2011. Structure and biology of trimeric autotransporter adhesins. Adv Exp Med Biol 715:143–158. doi: 10.1007/978-94-007-0940-9_9. [DOI] [PubMed] [Google Scholar]
- 11.N’Guessan PD, Vigelahn M, Bachmann S, Zabel S, Opitz B, Schmeck B, Hippenstiel S, Zweigner J, Riesbeck K, Singer BB, Suttorp N, Slevogt H. 2007. The UspA1 protein of Moraxella catarrhalis induces CEACAM-1-dependent apoptosis in alveolar epithelial cells. J Infect Dis 195:1651–1660. doi: 10.1086/514820. [DOI] [PubMed] [Google Scholar]
- 12.Nordström T, Blom AM, Forsgren A, Riesbeck K. 2004. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol 173:4598–4606. doi: 10.4049/jimmunol.173.7.4598. [DOI] [PubMed] [Google Scholar]
- 13.Nordström T, Blom AM, Tan TT, Forsgren A, Riesbeck K. 2005. Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity. J Immunol 175:3628–3636. doi: 10.4049/jimmunol.175.6.3628. [DOI] [PubMed] [Google Scholar]
- 14.Attia AS, Ram S, Rice PA, Hansen EJ. 2006. Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun 74:1597–1611. doi: 10.1128/IAI.74.3.1597-1611.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Liu G, Gradstedt H, Ermert D, Englund E, Singh B, Su YC, Johansson ME, Aspberg A, Agarwal V, Riesbeck K, Blom AM. 2016. Moraxella catarrhalis evades host innate immunity via targeting cartilage oligomeric matrix protein. J Immunol 196:1249–1258. doi: 10.4049/jimmunol.1502071. [DOI] [PubMed] [Google Scholar]
- 16.Shoulders MD, Raines RT. 2009. Collagen structure and stability. Annu Rev Biochem 78:929–958. doi: 10.1146/annurev.biochem.77.032207.120833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gelse K, Pöschl E, Aigner T. 2003. Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev 55:1531–1546. doi: 10.1016/j.addr.2003.08.002. [DOI] [PubMed] [Google Scholar]
- 18.Kadler KE, Baldock C, Bella J, Boot-Handford RP. 2007. Collagens at a glance. J Cell Sci 120:1955–1958. doi: 10.1242/jcs.03453. [DOI] [PubMed] [Google Scholar]
- 19.Singh B, Fleury C, Jalalvand F, Riesbeck K. 2012. Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host. FEMS Microbiol Rev 36:1122–1180. doi: 10.1111/j.1574-6976.2012.00340.x. [DOI] [PubMed] [Google Scholar]
- 20.Wachsmuth L, Söder S, Fan Z, Finger F, Aigner T. 2006. Immunolocalization of matrix proteins in different human cartilage subtypes. Histol Histopathol 21:477–485. [DOI] [PubMed] [Google Scholar]
- 21.Liu X, Wu H, Byrne M, Krane S, Jaenisch R. 1997. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A 94:1852–1856. doi: 10.1073/pnas.94.5.1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mundel TM, Kalluri R. 2007. Type IV collagen-derived angiogenesis inhibitors. Microvasc Res 74:85–89. doi: 10.1016/j.mvr.2007.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Abdillahi SM, Bober M, Nordin S, Hallgren O, Baumgarten M, Erjefält J, Westergren-Thorsson G, Bjermer L, Riesbeck K, Egesten A, Mörgelin M. 2015. Collagen VI is upregulated in COPD and serves both as an adhesive target and a bactericidal barrier for Moraxella catarrhalis. J Innate Immun 7:506–517. doi: 10.1159/000381213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bullard B, Lipski S, Lafontaine ER. 2007. Regions important for the adhesin activity of Moraxella catarrhalis Hag. BMC Microbiol 7:65. doi: 10.1186/1471-2180-7-65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Su YC, Hallström BM, Bernhard S, Singh B, Riesbeck K. 2013. Impact of sequence diversity in the Moraxella catarrhalis UspA2/UspA2H head domain on vitronectin binding and antigenic variation. Microbes Infect 15:375–387. doi: 10.1016/j.micinf.2013.02.004. [DOI] [PubMed] [Google Scholar]
- 26.Jiang X, Ruiz T, Mintz KP. 2011. The extended signal peptide of the trimeric autotransporter EmaA of Aggregatibacter actinomycetemcomitans modulates secretion. J Bacteriol 193:6983–6994. doi: 10.1128/JB.05813-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Schmidgen T, Kaiser PO, Ballhorn W, Franz B, Göttig S, Linke D, Kempf VA. 2014. Heterologous expression of Bartonella adhesin A in Escherichia coli by exchange of trimeric autotransporter adhesin domains results in enhanced adhesion properties and a pathogenic phenotype. J Bacteriol 196:2155–2165. doi: 10.1128/JB.01461-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Narayanan AS, Page RC, Swanson J. 1989. Collagen synthesis by human fibroblasts. Regulation by transforming growth factor-beta in the presence of other inflammatory mediators. Biochem J 260:463–469. doi: 10.1042/bj2600463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kranenburg AR, Willems-Widyastuti A, Moori WJ, Sterk PJ, Alagappan VK, de Boer WI, Sharma HS. 2006. Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease. Am J Clin Pathol 126:725–735. doi: 10.1309/JC477FAEL1YKV54W. [DOI] [PubMed] [Google Scholar]
- 30.Jankowich MD, Rounds SI. 2012. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 141:222–231. doi: 10.1378/chest.11-1062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.King TE Jr., Pardo A, Selman M. 2011. Idiopathic pulmonary fibrosis. Lancet 378:1949–1961. doi: 10.1016/S0140-6736(11)60052-4. [DOI] [PubMed] [Google Scholar]
- 32.Chilosi M, Poletti V, Rossi A. 2012. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res 13:3. doi: 10.1186/1465-9921-13-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Brooks MJ, Sedillo JL, Wagner N, Wang W, Attia AS, Wong H, Laurence CA, Hansen EJ, Gray-Owen SD. 2008. Moraxella catarrhalis binding to host cellular receptors is mediated by sequence-specific determinants not conserved among all UspA1 protein variants. Infect Immun 76:5322–5329. doi: 10.1128/IAI.00572-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Leo JC, Elovaara H, Bihan D, Pugh N, Kilpinen SK, Raynal N, Skurnik M, Farndale RW, Goldman A. 2010. First analysis of a bacterial collagen-binding protein with collagen toolkits: promiscuous binding of YadA to collagens may explain how YadA interferes with host processes. Infect Immun 78:3226–3236. doi: 10.1128/IAI.01057-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Zong Y, Xu Y, Liang X, Keene DR, Höök A, Gurusiddappa S, Höök M, Narayana SV. 2005. A “collagen hug” model for Staphylococcus aureus CNA binding to collagen. EMBO J 24:4224–4236. doi: 10.1038/sj.emboj.7600888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Brooks MJ, Sedillo JL, Wagner N, Laurence CA, Wang W, Attia AS, Hansen EJ, Gray-Owen SD. 2008. Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function. Infect Immun 76:5330–5340. doi: 10.1128/IAI.00573-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Roth J. 1996. The silver anniversary of gold: 25 years of the colloidal gold marker system for immunocytochemistry and histochemistry. Histochem Cell Biol 106:1–8. doi: 10.1007/BF02473197. [DOI] [PubMed] [Google Scholar]
- 38.Oehmcke S, Mörgelin M, Herwald H. 2009. Activation of the human contact system on neutrophil extracellular traps. J Innate Immun 1:225–230. doi: 10.1159/000203700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Nummelin H, Merckel MC, Leo JC, Lankinen H, Skurnik M, Goldman A. 2004. The Yersinia adhesin YadA collagen-binding domain structure is a novel left-handed parallel beta-roll. EMBO J 23:701–711. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.